Sign Up to Receive Email Updates:

Highlighted Courses

CDK4/6 Inhibition in Breast Cancer

CDK4/6 Inhibition in Breast Cancer   Course Description “CDK4/6 Inhibition in Breast Cancer” This program discusses the history of targeted therapies in breast cancer and the emerging role of CDK4/6 treatments. It gives an...

read more
Biosimilars in Oncology: A Virtual Roundtable

Biosimilars in Oncology: A Virtual Roundtable

Course - Biosimilars and Oncology: A Virtual Roundtable THIS PROGRAM IS NO LONGER AVAILABLE FOR CME CREDIT   Course Description “Biosimilars in Oncology: A Virtual Roundtable” This program is an audio archive of an expert virtual roundtable on biosimilars in...

read more
About the xME Institute

The xME Institute is a not-for-profit institution focused on the key role of the microenvironment in driving and controlling disease. At the cellular and molecular level, the microenvironment embraces blood vessels, immune cells, fibroblasts, inflammatory cells, extracellular matrix, and signaling molecules. At the treatment level, the microenvironment lies at the heart of today’s most transformative frontiers including immuno-oncology, precision medicine, gene therapy, angiogenesis, and regenerative medicine. The Institute is highly respected for its third-party objectivity, deep scientific and clinical knowledge, and global networks of healthcare professionals and researchers. A core aim of the xME Institute is to generate expert curricula on emerging therapies that optimize pathways within the cellular and molecular microenvironment. ACCME-accredited programs give clinicians, scientists, researchers, nurses, and other scientific and medical experts state-of-the-art courses covering late-breaking clinical data and concepts.

Get in Touch

9 + 13 =